Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-1659
Bioorg Med Chem Lett 2005 Sep 01;1517:3874-80. doi: 10.1016/j.bmcl.2005.05.118.
Show Gene links Show Anatomy links

The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion.

Papke RL, Zheng G, Horenstein NA, Dwoskin LP, Crooks PA.


???displayArticle.abstract???
The alpha7 nAChR subtype is of particular interest as a potential therapeutic target since it has been implicated as a mediator of both cognitive and neuroprotective activity. The rigid nicotine analog ACME and the N-cyanoborane conjugate ACME-B are selective partial agonists of rat alpha7 receptors expressed in Xenopus oocytes, with no significant activation of either alpha3beta4 or alpha4beta2 receptors. ACME-B is both more potent and efficacious than ACME. The efficacies of ACME-B and ACME are approximately 26% and 10% of the efficacy of ACh, respectively. Similar N-conjugation of S(-)nicotine with cyanoborane decreased efficacy for alpha3beta4 and alpha4beta2 receptors, as well as for alpha7 nAChR. Structural comparison of ACME with the benzylidene anabaseines, another class of previously identified alpha7-selective agonists, suggests that they share a similar structural motif that may be applicable to other alpha7-selective agonists.

???displayArticle.pubmedLink??? 16005216
???displayArticle.pmcLink??? PMC3593044
???displayArticle.link??? Bioorg Med Chem Lett
???displayArticle.grants??? [+]

Species referenced: Xenopus
Genes referenced: chrna4

References [+] :
Adler, Schizophrenia, sensory gating, and nicotinic receptors. 1998, Pubmed